These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21309045)

  • 21. The National Diabetes Register in Sweden: an implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care.
    Gudbjörnsdottir S; Cederholm J; Nilsson PM; Eliasson B;
    Diabetes Care; 2003 Apr; 26(4):1270-6. PubMed ID: 12663609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
    Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
    J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes.
    Mi SH; Su G; Li Z; Yang HX; Zheng H; Tao H; Zhou Y; Tian L
    Chin Med J (Engl); 2012 Jan; 125(1):38-43. PubMed ID: 22340463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.
    Ferrara A; Karter AJ; Ackerson LM; Liu JY; Selby JV;
    Diabetes Care; 2001 Jul; 24(7):1144-50. PubMed ID: 11423493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
    Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
    Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes.
    Ibáñez B; Galbete A; Goñi MJ; Forga L; Arnedo L; Aizpuru F; Librero J; Lecea O; Cambra K
    BMC Public Health; 2018 Mar; 18(1):408. PubMed ID: 29587788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of health literacy with diabetes outcomes.
    Schillinger D; Grumbach K; Piette J; Wang F; Osmond D; Daher C; Palacios J; Sullivan GD; Bindman AB
    JAMA; 2002 Jul 24-31; 288(4):475-82. PubMed ID: 12132978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.
    Buse JB; Rubin CJ; Frederich R; Viraswami-Appanna K; Lin KC; Montoro R; Shockey G; Davidson JA
    Clin Ther; 2005 Aug; 27(8):1181-95. PubMed ID: 16199244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with high glycated hemoglobin levels (≥5.7%) in Korean adults with normal fasting glucose.
    Choi SY; Yun KE; Choi HJ
    J Endocrinol Invest; 2012 Sep; 35(8):730-4. PubMed ID: 21970859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.
    Sung KC; Rhee EJ
    Diabet Med; 2007 Aug; 24(8):848-54. PubMed ID: 17650158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and Sex.
    Altay S; Onat A; Karadeniz Y; Özpamuk-Karadeniz F; Can G
    J Investig Med; 2015 Aug; 63(6):821-7. PubMed ID: 26107424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetes.
    Müller N; Kloos C; Frank T; Ristow M; Wolf G; Müller UA
    Diabet Med; 2011 Feb; 28(2):223-6. PubMed ID: 21219434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11).
    Landman GW; van Hateren KJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Br J Gen Pract; 2010 Mar; 60(572):172-5. PubMed ID: 20202363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between glycated haemoglobin levels and mean glucose levels over time.
    Nathan DM; Turgeon H; Regan S
    Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvements in glycaemic control and cholesterol concentrations associated with the Quality and Outcomes Framework: a regional 2-year audit of diabetes care in the UK.
    Oluwatowoju I; Abu E; Wild SH; Byrne CD
    Diabet Med; 2010 Mar; 27(3):354-9. PubMed ID: 20536500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE; Goldberg RB; Truitt KE; Jones MR
    Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study.
    Greenfield S; Billimek J; Pellegrini F; Franciosi M; De Berardis G; Nicolucci A; Kaplan SH
    Ann Intern Med; 2009 Dec; 151(12):854-60. PubMed ID: 20008761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study.
    Elley CR; Kenealy T; Robinson E; Drury PL
    Diabet Med; 2008 Nov; 25(11):1295-301. PubMed ID: 19046219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
    Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.